Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 487.00
-0.50 (-0.10%)
Aug 14, 2026, 5:07 PM GMT
Oxford Biomedica Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Oxford Biomedica stock has a consensus rating of "Strong Buy" and an average price target of 786p. The average 1-year stock price forecast is 61.43% higher than the current stock price, while the lowest is 550p (+12.94%) and the highest is 900p (+84.80%).
Price Target: 786p (+61.43%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Oxford Biomedica stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates 1,140p → 900p | Buy | Reiterates | 1,140p → 900p | +84.80% | Aug 10, 2026 |
| Jefferies | Jefferies | Buy Reiterates 827p | Buy | Reiterates | 827p | +69.82% | Jun 3, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates 950p | Buy | Reiterates | 950p | +95.07% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
213.56M
from 168.74M
Increased by 26.56%
Revenue Next Year
268.93M
from 213.56M
Increased by 25.93%
EPS This Year
-0.16
from -0.27
EPS Next Year
0.06
from -0.16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.